Amphastar Pharmaceuticals, Inc
NASDAQ:AMPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Amphastar Pharmaceuticals, Inc
NASDAQ:AMPH
|
US |
|
Alpine Income Property Trust Inc
NYSE:PINE
|
US |
|
DBS Group Holdings Ltd
F:DEV
|
SG |
|
S
|
Sony Group Corp
F:SONA
|
JP |
|
F
|
Funding Circle Holdings PLC
F:FCA
|
UK |
Intrinsic Value
Is AMPH undervalued or overvalued?
See the intrinsic value estimate for Amphastar Pharmaceuticals, Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
AMPH looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with AMPH’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Amphastar Pharmaceuticals Does
Amphastar Pharmaceuticals makes and sells injectable, inhalation, and intranasal medicines that are used in hospitals, emergency care, and other clinical settings. Its products include both branded and generic drugs, along with active pharmaceutical ingredients and certain drug-device combinations. The company focuses on medicines that are often hard to manufacture and supply consistently, which gives it a role in the lower-cost end of the pharmaceutical market.
- Headquarters
- United States of America US
- Employees
- 1 976
- IPO date
- Jun 25, 2014
Revenue & Expenses Breakdown
Amphastar Pharmaceuticals, Inc
Earnings Waterfall
Amphastar Pharmaceuticals, Inc
The intrinsic value for Amphastar Pharmaceuticals, Inc (AMPH) under the Base Case is hidden USD.
Compared with the current market price of 26 USD, the stock appears hidden.